Skip to main navigation
Skip to search
Skip to main content
Scholars @ UT Health San Antonio Home
Help & FAQ
English
Español
Home
Profiles
Research units
Publications
Datasets
Search by expertise, name or affiliation
A tetracycline-repressible transactivator approach suggests a shorter half-life for tyrosine hydroxylase mRNA
David Foster
,
Randy Strong
, William W. Morgan
Barshop Institute
Department of Cell Systems & Anatomy
Research output
:
Contribution to journal
›
Article
›
peer-review
7
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'A tetracycline-repressible transactivator approach suggests a shorter half-life for tyrosine hydroxylase mRNA'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Chemistry
Tyrosine
100%
Messenger RNA
63%
Tetracycline
36%
Reaction Half Life
36%
Doxycycline
18%
Biosynthesis
9%
Catecholamine
9%
Actinomycin D
9%
Procedure
9%
Concentration
9%
Rate
9%
Degradation
9%
Biochemistry, Genetics and Molecular Biology
Tyrosine Hydroxylase
100%
Messenger RNA
63%
Life
36%
Transcription
27%
Nested Gene
9%
Degradation
9%
Anabolism
9%
Lysozyme
9%
Chimeric Gene
9%
Catecholamine Release
9%
Regulatory Mechanism
9%
Rat
9%
Pharmacology, Toxicology and Pharmaceutical Science
Tyrosine 3 Monooxygenase
100%
Messenger RNA
63%
Tetracycline
27%
Doxycycline
18%
Enzyme
9%
Catecholamine
9%
Dactinomycin
9%
Tetracycline Derivative
9%
Absence
9%
Rat
9%